Arbutus to Present Imdusiran Data at EASL Congress 2024
22 mai 2024 02h00 HE
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., May 22, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...